Trinity Biotech | TRIB - Pre Tax Profit

Stock Price
0.57
Daily Change
-0.01 -0.88%
Monthly
-23.44%
Yearly
-29.99%
Q2 Forecast
0.56

Trinity Biotech reported $-5.06M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Abbott USD 2.39B 27M Mar/2026
Bayer EUR -3.37B 2.21B Dec/2025
Bio-Rad Laboratories USD 929.2M 846.3M Dec/2025
EDAP TMS EUR -4.91M 597K Sep/2025
J&J USD 7.82B 2.86B Mar/2026
Mesa Laboratories USD -2.22M 6.03M Dec/2024
OraSure Technologies USD -18.43M 5.14M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Siemens EUR 2.94B 559M Dec/2025
Surmodics USD -5.9M 1.61M Jun/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025
Tosoh JPY 29.77B 1.16B Mar/2026
Trinity Biotech USD -5.06M 10.74M Sep/2025
Veracyte USD 29.97M 10.66M Mar/2026